Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
November 12, 2024 16:05 ET
|
Dyadic International, Inc.
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
Recombinant Cell Culture Supplements Market Booms with a Projected Market Value of US$ 947.7 million by 2033 - Persistence Market Research
June 05, 2023 09:39 ET
|
Persistence Market Research
New York, June 05, 2023 (GLOBE NEWSWIRE) -- The global recombinant cell culture supplements market size was valued at US$ 495.5 million in 2022 and is projected to reach US$ 947.7 million by 2033,...